March 16, 2020 A vision for achieving worldwide biopharmaceutical CDMO leadership

CEO Frank Mathias’ article on Strategy 2025

"The sustainability of a promising long-term vision cannot be governed by financial KPIs alone. No, we had to catapult ourselves into the future. We had to gather insights on what the world, the society, and the industry of tomorrow would look like, in order to chart our path into the future. I was convinced that, if we followed the right approach, financial success was bound to follow. What followed next was a fantastic adventure around the world together with my team, which laid the foundation for what was to become our 'Strategy 2025'", says CEO Frank Mathias" in his recent article in Pharma's Almanac.

Learn more about how the strategy was forged, what makes it unique and how Rentschler Biopharma plans to revolutionize the global CDMO landscape.